Sonographic Monitoring of Growth of Uterine Myomas in Untreated Women and Respective Influence Factors
Geburtshilfe und Frauenheilkunde · 01.04.2023 · 83 (04) · 446-452
DOI: 10.1055/a-1996-2980 ↗Kurz gefasst
Fachartikel in der Zeitschrift Geburtshilfe und Frauenheilkunde, erschienen am 01.04.2023. Verfasst von Vera Seidel und 4 weiteren Autor:innen. Beteiligte Einrichtung: Obstetrics, Charité - Universitätsmedizin Berlin, Berlin, Germany. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Research Question What are the growth patterns of uterine myomas in untreated premenopausal women? Which factors influence the growth rate of uterine myomas in premenopausal women?
Method
All premenopausal women who presented to the outpatient myoma consultation clinic between January 2005 and March 2022 at least twice were screened. Exclusion criteria were hormonal therapy, pregnancy, and postmenopausal status.
Results
A total of 189 patients were included in our study which focused on the respective largest uterine myoma of each woman. An ideal linear growth over time was assumed. Most myomas (82%) increased in size. The mean annual growth of these myomas was 68.42 cm3. The most important prognostic factor for growth was the initial size of the myoma. The absolute annual growth of myomas measuring > 50 cm3 at first presentation was higher compared to smaller myomas (p < 0.001). The relative annual growth rate was highest for myomas measuring between 20 and 50 cm3 at the initial presentation (p = 0.003). The relative annual growth rate in women older than 40 years was significantly lower than that in women below the age of 40 years (p = 0.003).
Conclusion
Overall, it is difficult to make an individual prognosis about the growth pattern of a uterine myoma in a specific patient. It should be noted especially in asymptomatic patients that spontaneous regression of myoma size can also occur in premenopausal women.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Obstetrics, Charité - Universitätsmedizin Berlin, Berlin, Germany.
- Klinik für Gynäkologie, Charité Campus Virchow-Klinikum, Berlin, Germany.
- Institut für Biometrie und Klinische Epidemiologie, Charité Universitätsmedizin Berlin, Berlin, Germany.
- SOSTANA GmbH, Berlin, Germany.
Zitieren
APA
Seidel, V., Wernecke, K. D., Bellingkrodt, A. L., Armbrust, R., & David, M. (2023). Sonographic Monitoring of Growth of Uterine Myomas in Untreated Women and Respective Influence Factors. Geburtshilfe und Frauenheilkunde, 83(04), 446-452. https://doi.org/10.1055/a-1996-2980
Vancouver
Seidel V, Wernecke KD, Bellingkrodt AL, Armbrust R, David M. Sonographic Monitoring of Growth of Uterine Myomas in Untreated Women and Respective Influence Factors. Geburtshilfe und Frauenheilkunde. 2023;83(04):446-452. doi:10.1055/a-1996-2980
BibTeX
@article{Seidel2023,
author = {Seidel, Vera and Wernecke, Klaus Dieter and Bellingkrodt, Antonia Lukrezia and Armbrust, Robert and David, Matthias},
title = {Sonographic Monitoring of Growth of Uterine Myomas in Untreated Women and Respective Influence Factors},
journal = {Geburtshilfe und Frauenheilkunde},
year = {2023},
volume = {83},
number = {04},
pages = {446--452},
doi = {10.1055/a-1996-2980}
}
EUVIMED